Read E.V.I.dently Today for current news about health policy and events, among other topics.
E.V.I.dently Today Blog
A study in Health Affairs considers how health care decision-makers can incorporate the benefits associated with a medical treatment when assessing its societal value.
National Pharmaceutical Council President and CEO Dan Leonard discusses research that uncovers the reasons for discrepancies in coverage decisions.
A study by NPC suggests that while value-based arrangements can be one of many tools that payers leverage to address rising costs, it is also important to recognize the strengths and limitations associated with this model and what these tools can realistically achieve.
Lisa Yourman, the mother of two adult children living with cystic fibrosis and the Coalition Chair for Action CF, discusses how advances in medicine and technology are making a difference for her family and others.
A study from NPC and RTI Health Solutions evaluated how institutional barriers prevent the inclusion of broader individual and societal benefits associated with new health care innovations from being considered when assessing the value of medical treatments and making health care coverage determinations.
QALY Remains a Challenge, Societal Perspective Presents an Opportunity With ICER’s 2020 Value Assessment Framework
NPC evaluates the extent to which ICER's 2020-2023 value assessment framework addresses needed changes.